Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
19.01
-0.28 (-1.45%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $1.52 billion as of April 28, 2026. Its market cap has increased by 495.89% in one year.
Market Cap
1.52B
Enterprise Value
1.18B
1-Year Change
495.89%
Ranking
Category
Stock Price
$19.01
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $1.52B, an increase of 79.94%. That is a compound annual growth rate of 12.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.54B | 51.17% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AtaiBeckley | 1.69B |
| Vir Biotechnology | 1.67B |
| Generate Biomedicines | 1.63B |
| Intellia Therapeutics | 1.61B |
| Nanobiotix | 1.60B |
| Oculis Holding AG | 1.56B |
| Immatics | 1.52B |
| MBX Biosciences | 1.52B |